# Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol

> **NCT02501954** · PHASE3 · COMPLETED · sponsor: **Women's Cancer Care Associates, LLC** · enrollment: 48 (actual)

## Conditions studied

- Endometrial Clear Cell Adenocarcinoma
- Endometrial Serous Adenocarcinoma
- Stage IIIA Uterine Corpus Cancer
- Stage IIIB Uterine Corpus Cancer
- Stage IIIC Uterine Corpus Cancer
- Stage IVA Uterine Corpus Cancer

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Carboplatin
- **DRUG:** Paclitaxel
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT02501954
- **Lead sponsor:** Women's Cancer Care Associates, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2023-11
- **Final completion:** 2023-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02501954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02501954, "Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02501954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*